Evidence map›Paper›PMID 23224634›Full record

ArticleWiener medizinische Wochenschrift (1946)2013

Sulforaphane and related mustard oils in focus of cancer prevention and therapy.

Ingrid Herr, Vladimir Lozanovski, Philipp Houben, Peter Schemmer, Markus W Büchler

Abstract read
PubMed Publisher
In one paragraph

Article in Wiener medizinische Wochenschrift (1946), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Antiproliferative Effect of Indole Phytoalexins.Molecules (Basel, Switzerland) · 2016
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ingrid HerrMolecular OncoSurgery Group, University of Heidelberg and German Cancer Research Center-G403, Im Neuenheimer Feld 365, 69120 Heidelberg, Germany. i.herr@dkfz.de
Vladimir Lozanovski
Philipp Houben
Peter Schemmer
Markus W Büchler
German Cancer Research Center · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The plant family Brassicaceae, formerly Cruciferae, contains mustard oil glycosides, from which mustard oils are enzymatically hydrolyzed. Mustard oils offer protection from pests, microorganisms and fungi. More than 120 different mustard oils with various biological functions are known. Since ancient times, these substances are used as natural antibiotics, antiviral drugs and antimycotics. The antioxidative effect of mustard oils contributes to protection from DNA damage. Epidemiological and experimental studies have shown preventive and therapeutic effects of crucifers or isolated substances thereof. Particularly well studied is the mustard oil sulforaphane, which is contained in high concentrations in broccoli and its sprouts. As has been shown in mice recently, sulforaphane also targets the most malignant cancer stem cells, which are not affected by conventional cancer treatments. Based on these promising results, the first prospective clinical studies with cancer patients and sulforaphane-enriched broccoli sprouts have now been initiated in the United States.

Indexed as

AnimalsAnticarcinogenic AgentsBrassicaCase-Control StudiesDNA DamageFeeding BehaviorGlucosinolatesHerb-Drug InteractionsHumansIsothiocyanatesMiceNeoplasmsNeoplasms, ExperimentalNeoplastic Stem CellsPhytotherapyPlant ExtractsAnticarcinogenic AgentsGlucosinolatesIsothiocyanatesPlant ExtractssulforaphaneSulfoxidesThiocyanates

Identifiers

PMID23224634
OpenAlexW1573986163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.